| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 6,884 | 7,315 | 8,344 | 8,839 |
| Cost of revenue | - | - | - | 3,599 |
| Cost of sales | 4,171 | 4,412 | 3,990 | - |
| Gross profit | 2,713 | 2,903 | 4,354 | 5,240 |
| General and administrative expense | - | - | - | 1,573 |
| General and administrative | 1,917 | 1,986 | 2,208 | - |
| Selling and marketing | 1,546 | 1,389 | 2,186 | 1,309 |
| Research and development | 1,819 | 1,471 | 2,606 | 863 |
| Total operating expenses | 5,282 | 4,846 | 7,000 | 3,745 |
| (loss) income from operations | -2,569 | -1,943 | -2,646 | 1,495 |
| Investment income, interest | - | - | - | 279 |
| Interest income, net | 160 | -183 | -184 | - |
| Other income, net | 160 | 183 | 184 | 279 |
| (loss) income before income tax | -2,409 | -1,760 | -2,462 | 1,774 |
| (benefit from) provision for income taxes | -1,466 | -723 | 110 | 559 |
| Net (loss) income | -943 | -1,037 | -2,572 | 1,215 |
| Net (loss) income per share - basic | -0.06 | -0.06 | -0.16 | 0.07 |
| Net (loss) income per share - diluted | -0.06 | -0.06 | -0.16 | 0.07 |
| Weighted average number of shares used in computing net (loss) income per share - basic | 16,320,036 | 16,320,036 | 16,341,867 | 16,321,131 |
| Weighted average number of shares used in computing net (loss) income per share - diluted | 16,320,036 | 16,320,036 | 16,341,867 | 16,345,749 |
Sensus Healthcare, Inc. (SRTS)
Sensus Healthcare, Inc. (SRTS)